Confirmation of the progesterone receptor as an efficient marker of treatment with 17β-estradiol in veal calves.
Under current European Union legislation the use of anabolic steroids in food-producing livestock is banned because of their long-term adverse effects on human health. We examined the expression profile of the immunohistochemical marker progesterone receptor in veal calves' sex accessory glands following experimental administration of anabolic compounds. The aim was to confirm the accuracy of the immunohistochemical approach in the detection of the over-expression of the progesterone receptor induced by the administration of sexual steroids at low levels (17β-estradiol and nandrolone alone or in combination). A total of 217 male veal calves were randomly divided into four groups: group A (104 calves) treated with 17β-estradiol (5 mg/head; 4 weekly injections); group B (20 calves) treated with nandrolone (50 mg/head; 4 weekly injections); group C (20 calves) treated with the association of the two steroids (5 mg estradiol + 50 mg nandrolone; 4 weekly injections); and group K (73 calves) kept as a control. All the sexual accessory glands were collected at the slaughterhouse (15 days after the last administration) and subjected to immunohistochemical staining with anti-progesterone receptor antibody. All the calves treated with 17β-estradiol alone or in association with nandrolone (groups A and C) showed strong positivity, while nandrolone-treated calves and controls (groups B and K) gave negative results to the immunohistochemical investigation. The statistical analysis showed that the progesterone receptor is a significant predictor of 17β-estradiol treatment alone or in association with nandrolone (p < 0.001): the immunohistochemical study resulted in 100% sensitivity (CI = 95%: 97.1-100%) and specificity (CI = 95%: 95.1-100%) for prostate and 99% sensitivity (CI = 95%: 95.6-100%) and 100% specificity (CI = 95%: 95.1-100%) for bulbo-urethral glands. The data confirm that this innovative biological approach offers a reliable tool to enhance the efficacy of the histological test to detect illegal treatments with estrogens alone or in association with androgens.
a Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta , Turin , Italy.
Marzia
M
Pezzolato
a Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta , Turin , Italy.
Mario
M
Botta
a Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta , Turin , Italy.
Elisa
E
Baioni
a Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta , Turin , Italy.
Guia Benedetta
GB
Richelmi
a Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta , Turin , Italy.
Danilo
D
Pitardi
a Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta , Turin , Italy.
Katia
K
Varello
a Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta , Turin , Italy.
Maria
M
Caramelli
a Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta , Turin , Italy.
Elena
E
Bozzetta
D000818:Animals; D015415:Biomarkers / Q000032:analysis; D002417:Cattle; D004958:Estradiol / Q000008:administration & dosage / Q000627:therapeutic use*; D007150:Immunohistochemistry / Q000592:standards*; D007273:Injections, Intramuscular; D008297:Male; D009277:Nandrolone / Q000008:administration & dosage / Q000627:therapeutic use; D011980:Receptors, Progesterone / Q000032:analysis*
D015415:Biomarkers; D011980:Receptors, Progesterone; D004958:Estradiol; D009277:Nandrolone
17β-estradiol; calves; illicit treatments; immunohistochemistry; nandrolone